Synthetic DNA Manufacturing Factory of the Future
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform.
Latest Press Releases
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly.
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
— Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
RSIP Neph Announces a Revolutionary Intra-op Solution for Partial Nephrectomy Surgeries
RSIP Neph (part of the RSIP Vision group) its new innovative intra-op solution that utilizes advanced Computer Vision and Artificial Intelligence algorithms, to enhance the next generation of robotic surgery.
Aculys Pharma and Four H Initiate Research Collaboration
Aculys Pharma, Inc. (“Aculys”), a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, and Four H, Inc. (“Four H”).
BRUKINSA® Approved in the U.S. for Chronic Lymphocytic Leukemia
BeiGene a global biotechnology company, that the U.S. Food and Drug Administration (FDA) has approved its Bruton’s tyrosine kinase inhibitor (BTKi).
Sai Life Sciences opens new High-Potency API Manufacturing facility at its Bidar Campus
Sai Life Sciences, one of India's fastest growing Contract Research, Development & Manufacturing Organizations (CRO-CDMO), the opening of a new High-Potency API (HPAPI) manufacturing facility at its cGMP API Manufacturing campus in Bidar, India.
Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®)
Servier and Taiho Oncology, Inc., the release of data from SUNLIGHT, a pivotal Phase 3 global trial evaluating the combination of trifluridine/tipiracil (LONSURF®).
Canada Royal Enoch Phytomedicine Launches Clinical Trial
Canada Royal Enoch Phytomedicine Ltd., an innovative leader in ginseng and ginsenosides research and application, has the launch of a new clinical trial.
Harrow Announces Availability of Fortisite™ Formulations for In-Office Use
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, the availability, for in-office use, of Fortisite™ (compounded Tobramycin 1.5% + Vancomycin 5%) from its FDA‑registered and FDA‑inspected ImprimisRx® 503B outsourcing facility.
CollPlant Enriches Portfolio of rhCollagen
CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing.
Scivita Medical celebrates trade show success and the strategy of "globalization"
Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair. Scivita Medical was able to a strategic cooperation with FUJIFILM Europe B.V.